Biology of Blood and Marrow Transplantation
Volume 16, Issue 8 , Pages 1180-1185 , August 2010

Prediction of Veno-Occlusive Disease Using Biomarkers of Endothelial Injury

Presented in abstract form at the American Society of Hematology Annual Meeting, San Francisco, California, December 2008 and at the American Society of Blood and Marrow Transplantation Annual Meeting, Tampa, Florida, February 2009.

  • Corey Cutler

      Affiliations

    • Division of Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
    • Corresponding Author InformationCorrespondence and reprint requests: Corey Cutler, MD MPH FRCP(C), Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, D1B13, Boston, MA 02115.
  • ,
  • Haesook T. Kim

      Affiliations

    • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Shaké Ayanian

      Affiliations

    • Laboratory Medicine, Children's Hospital Boston, Boston, Massachusetts
  • ,
  • Gary Bradwin

      Affiliations

    • Laboratory Medicine, Children's Hospital Boston, Boston, Massachusetts
  • ,
  • Carolyn Revta

      Affiliations

    • Division of Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Julie Aldridge

      Affiliations

    • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Vincent Ho

      Affiliations

    • Division of Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Edwin Alyea

      Affiliations

    • Division of Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • John Koreth

      Affiliations

    • Division of Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Philippe Armand

      Affiliations

    • Division of Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Robert Soiffer

      Affiliations

    • Division of Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Jerome Ritz

      Affiliations

    • Division of Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Paul G. Richardson

      Affiliations

    • Division of Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Joseph H. Antin

      Affiliations

    • Division of Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

Received 13 November 2009 ,Accepted 17 February 2010.

  • Image Result

    Biomarker levels stratified by sirolimus exposure and VOD outcome. Line plots of biomarker levels and time from transplantation, stratified into 4 clinical groups. Confidence intervals represent inter

    Biomarker levels stratified by sirolimus exposure and VOD outcome. Line plots of biomarker levels and time from transplantation, stratified into 4 clinical groups. Confidence intervals represent interquartile ranges.

 Financial disclosure: See Acknowledgments on page 1184.

PII: S1083-8791(10)00087-X

doi: 10.1016/j.bbmt.2010.02.016

Biology of Blood and Marrow Transplantation
Volume 16, Issue 8 , Pages 1180-1185 , August 2010